Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-((1r,5s)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)-1,2-oxazol-4-yl)methoxy)-8-azabicyclo(3.2.1)octan-8-yl)-4-fluoro-1,3-benzothiazole-6-carboxylic Acid
2. Ljn452
1. 1383816-29-2
2. Ljn452
3. Nvp-ljn452-nxa
4. Ljn-452
5. Tropifexor [inn]
6. Tropifexor [usan]
7. Tropifexor (ljn452)
8. Nmz08km76z
9. 2-[(1r,3r,5s)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic Acid
10. Tropifexor (usan)
11. Rel-2-((1r,3r,5s)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylic Acid
12. 2-((1r,5s)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)-1,2-oxazol-4-yl)methoxy)-8-azabicyclo(3.2.1)octan-8-yl)-4-fluoro-1,3-benzothiazole-6-carboxylic Acid
13. 2-[(1r,5s)-3-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]methoxy]-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic Acid
14. Ljn452; Tropifexor
15. Tropifexor [usan:inn]
16. Unii-nmz08km76z
17. Gtpl9725
18. Chembl4298169
19. Schembl17848159
20. Schembl19178329
21. Schembl20788139
22. Dtxsid001100225
23. Amy16804
24. Ex-a1934
25. Bdbm50527040
26. Mfcd31619256
27. S8733
28. Who 10443
29. Akos037648712
30. Compound 1 [pmid: 29148806]
31. Cs-8153
32. Ac-30341
33. Bs-15324
34. Hy-107418
35. D11548
36. F53709
37. A903437
38. 1383819-10-0
39. 2-((1r,3r,5s)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)-1,2-oxazol-4-yl)methoxy)-8- Azabicyclo(3.2.1)octan-8-yl)-4-fluoro-1,3-benzothiazole-6-carboxylic Acid
40. 2-((1r,5s)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylic Acid
41. 2-[(3-endo)-3-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-4-isoxazolyl]methoxy]-8-azabicyclo[3.2.1]oct-8-yl]-4-fluoro-6-benzothiazolecarboxylic Acid
42. 6-benzothiazolecarboxylic Acid, 2-((3-endo)-3-((5-cyclopropyl-3-(2- (trifluoromethoxy)phenyl)-4-isoxazolyl)methoxy)-8-azabicyclo(3.2.1)oct-8- Yl)-4-fluoro-
43. Gwf
| Molecular Weight | 603.6 g/mol |
|---|---|
| Molecular Formula | C29H25F4N3O5S |
| XLogP3 | 6.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 8 |
| Exact Mass | 603.14510473 g/mol |
| Monoisotopic Mass | 603.14510473 g/mol |
| Topological Polar Surface Area | 126 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 979 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of non-alcoholic steatohepatitis (NASH)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
22
PharmaCompass offers a list of Tropifexor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tropifexor manufacturer or Tropifexor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tropifexor manufacturer or Tropifexor supplier.
PharmaCompass also assists you with knowing the Tropifexor API Price utilized in the formulation of products. Tropifexor API Price is not always fixed or binding as the Tropifexor Price is obtained through a variety of data sources. The Tropifexor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tropifexor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tropifexor, including repackagers and relabelers. The FDA regulates Tropifexor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tropifexor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tropifexor supplier is an individual or a company that provides Tropifexor active pharmaceutical ingredient (API) or Tropifexor finished formulations upon request. The Tropifexor suppliers may include Tropifexor API manufacturers, exporters, distributors and traders.
Tropifexor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tropifexor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tropifexor GMP manufacturer or Tropifexor GMP API supplier for your needs.
A Tropifexor CoA (Certificate of Analysis) is a formal document that attests to Tropifexor's compliance with Tropifexor specifications and serves as a tool for batch-level quality control.
Tropifexor CoA mostly includes findings from lab analyses of a specific batch. For each Tropifexor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tropifexor may be tested according to a variety of international standards, such as European Pharmacopoeia (Tropifexor EP), Tropifexor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tropifexor USP).
